The effects of SRT1720 in improving the LV function in chagasic mice were associated with a significant increase in SIRT1 activity and deacetylation of PGC1α (Fig 3), as has also been noted in models of metabolic disease [37,38]. Here, PPARGC1A is linked to metabolic disease.